106 Pharmacokinetic variability of clarithromycin is due to differences in CYP3A4 activity in patients with cystic fibrosis (CF) – a reason for treatment failure?

• DOI: 10.1016/s1569-1993(11)60123-9
• Publication Date: 2011-06-23T02:56:34Z
• Authors: C.S. Dalbøge; X.C. Nielsen; K. Dalhoff; M. Dunø; A. Buchara; J.-W.C. Alffenaar; T. Pressler; N. Høiby; H.K. Johansen
• Keywords: Pulmonary and Respiratory Medicine; 03 medical and health sciences; 0302 clinical medicine; Pediatrics, Perinatology, and Child Health